Study Finds GAE Relieves Knee Osteoarthritis Pain in 80% of 194 Patients for 12 Months
Updated
Updated · ScienceDaily · Jun 18
Study Finds GAE Relieves Knee Osteoarthritis Pain in 80% of 194 Patients for 12 Months
3 articles · Updated · ScienceDaily · Jun 18
Summary
194 knee osteoarthritis patients who had failed at least three months of conservative treatment saw durable gains after genicular artery embolization with resorbable microspheres, with 80% still meeting a clinically meaningful pain-improvement threshold at 12 months.
Pain scores on a 0-to-10 scale fell from a median 7 before treatment to 4 at six weeks and 3 at both six and 12 months, while daily activity, sports, symptoms, pain and quality-of-life scores all improved.
239 procedures were performed, including both knees in 45 patients, and every treatment was technically successful under fluoroscopic guidance.
Safety was a key finding: no moderate or severe adverse events were reported, and only 6.7% of patients had mild reactions that resolved on their own.
The single-center Radiology study positions GAE as a minimally invasive option between injections and knee replacement for the more than 365 million adults worldwide living with knee osteoarthritis.